Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae

Margo Diricks(Leibniz Association), Matthias Merker(German Center for Infection Research), Inken Wohlers(Research Center Borstel - Leibniz Lung Center), Thiên‐Trí Lâm(University of Würzburg), Christian Utpatel(German Center for Infection Research), Susanne Hauswaldt(University Hospital Schleswig-Holstein), Stefan Niemann(Centre National de la Recherche Scientifique), Jan Rupp(University Hospital Schleswig-Holstein), Omar Jiménez Vázquez(Research Center Borstel - Leibniz Lung Center), Lennart Bartels(Research Center Borstel - Leibniz Lung Center), Maria Paula Bajanca-Lavado(National Institute of Health Dr. Ricardo Jorge), Ricardo Stolze(Research Center Borstel - Leibniz Lung Center), Heike Claus(University of Würzburg)
Genome Medicine
December 4, 2024
10.1186/s13073-024-01406-4
Cited by 20

Related Papers

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
|The Lancet Digital Health|2021|536
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
|Clinical Infectious Diseases|2018|256
Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains
|PLoS Pathogens|2009|225
Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4
|JAMA|2012|170
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
|The Lancet Digital Health|2023|157